A Study of HDM2012 in Patients With Advanced Solid Tumor

Clinical trial NCT07100249 · RECRUITING

Trial details

NCT number: NCT07100249
Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2025-08-06
Primary completion: 2027-10-01
Enrollment: 129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.